EnCare Biotech
Latest round
- Series A
Last raised
- Nov 2014
Total raised
- $6.8M
Investors
- 2
About EnCare Biotech
V.V. was founded in 2014 and operates out of Utrecht, Netherlands. The firm specializes in biotechnological solutions and has not undergone significant pivots in its business strategy. The company was initially established by a team with a background in biotech innovations.Encare Biotech specializes in developing and providing advanced biotechnological solutions aimed at enhancing healthcare outcomes. The company's core product offerings include a range of biopharmaceuticals and diagnostic tools designed to address specific health challenges, particularly in the fields of oncology and infectious diseases. These products are engineered to function by targeting disease mechanisms, thereby improving patient management and treatment efficacy. Encare Biotech serves a diverse client base, including hospitals, research institutions, and pharmaceutical companies, primarily in North America and Europe.Encare Biotech generates revenue through a structured model involving direct sales and partnerships with healthcare providers and institutions. The company engages in B2B transactions, supplying its biopharmaceutical products and diagnostic tools to hospitals and clinics, which incorporate them into their treatment protocols. The pricing structure for these products reflects their specialized nature, with flagship offerings commanding premium prices due to their unique therapeutic benefits. Encare Biotech also explores collaborative agreements with larger pharmaceutical firms, allowing for shared research and development efforts, which can enhance their market reach and profitability. The company aims to launch several new biopharmaceuticals by late 2025 and is actively exploring expansion into North American and European markets, enhancing its presence in these regions by establishing new partnerships and distribution agreements. This strategic approach is designed to bolster their market position and drive future revenue growth.
Who invested in EnCare Biotech
2 investors across 1 round
See all investors in EnCare Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 17, 2014
Amount
$6.8M
Investors
Questions about EnCare Biotech
Who invested in EnCare Biotech?
EnCare Biotech has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EnCare Biotech raised?
EnCare Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EnCare Biotech last raise money?
EnCare Biotech's most recent round on record is a Series A, in Nov 2014.
What does EnCare Biotech do?
EnCare Biotech is a biotechnology company.
Where is EnCare Biotech headquartered?
EnCare Biotech is headquartered in Utrecht, Netherlands.
Which VCs invest in companies like EnCare Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at EnCare Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like EnCare Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.